| Why Is Infant Mortality Higher in the United States Than in Europe? A Chen, E Oster, H Williams American economic journal. Economic policy 8 (2), 89, 2016 | 233* | 2016 |
| Health Care Spending: Historical Trends and New Directions A Chen, D Goldman Annual Review of Economics 8, 291-319, 2016 | 34 | 2016 |
| Do the poor benefit from more generous Medicaid physician payments A Chen Social Science Research Network Working Paper Series, 2014 | 33* | 2014 |
| Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses A Chen, D Lakdawalla Journal of Health Economics, 2019 | 29* | 2019 |
| Uptake of infliximab biosimilars among the Medicare population AJ Chen, L Gascue, R Ribero, K Van Nuys JAMA Internal Medicine 180 (9), 1255-1256, 2020 | 25 | 2020 |
| When does weight matter most? AJ Chen Journal of health economics 31 (1), 285-295, 2012 | 21 | 2012 |
| Graduating into a downturn: Are physicians recession proof? A Chen, AL Sasso, MR Richards Health economics 27 (1), 223-235, 2018 | 17 | 2018 |
| Provider differences in biosimilar uptake in the filgrastim market. AJ Chen, R Ribero, K Van Nuys The American Journal of Managed Care 26 (5), 208-213, 2020 | 15 | 2020 |
| Does Spending More Get More? Health Care Delivery and Fiscal Implications From a Medicare Fee Bump AJ Chen, AJ Graves, MJ Resnick, MR Richards Journal of Policy Analysis and Management 37 (4), 706-731, 2018 | 15 | 2018 |
| Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances A Chen, DM Blumenthal, AB Jena JAMA Network Open 1 (8), e185805-e185805, 2018 | 14 | 2018 |
| Value of reducing wait times for chimeric antigen receptor T-cell treatment: Evidence from randomized controlled trial data on tisagenlecleucel for diffuse large B-cell lymphoma AJ Chen, J Zhang, A Agarwal, DN Lakdawalla Value in Health 25 (8), 1344-1351, 2022 | 13 | 2022 |
| Understanding the Latest ACO “Savings”: Curb Your Enthusiasm and Sharpen Your Pencils—Part 1 JM McWilliams, AJ Chen Health Affairs Forefront, 2020 | 12 | 2020 |
| Supply‐side effects from public insurance expansions: Evidence from physician labor markets A Chen, AT Lo Sasso, MR Richards Health economics 27 (4), 690-708, 2018 | 12 | 2018 |
| Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer: Study examines spending on targeted therapies for patients with advanced-stage … M Li, DP Goldman, AJ Chen Health Affairs 40 (5), 763-771, 2021 | 8 | 2021 |
| Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017 AJ Chen, X Hu, RM Conti, AB Jena, DP Goldman Value in Health 22 (12), 1387-1395, 2019 | 8 | 2019 |
| Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials AJ Chen, DP Goldman Value in Health 21 (8), 905-910, 2018 | 8 | 2018 |
| From vision to design in advancing Medicare payment reform: a blueprint for population‐based payments JM McWilliams, A Chen, ME Chernew Washington, DC: Brookings Institution, 2021 | 7 | 2021 |
| The Extent of Externalities from Medicare Payment Policy AJ Chen, MR Richards, CM Whaley, X Zhao | 7 | 2020 |
| Provider turf wars and Medicare payment rules AJ Chen, EL Munnich, ST Parente, MR Richards Journal of Public Economics 218, 104812, 2023 | 5 | 2023 |
| Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share: Study examines market share competition for cancer drug trastuzumab and its biosimilars AJ Chen, KM Kaiser, L Gascue, MA Manetas, K Van Nuys Health Affairs 42 (6), 779-784, 2023 | 4 | 2023 |
